Dr. Thomas T Amatruda MD Hematologist

Dr. Thomas Amatruda is a hematologist in Fridley, Minnesota and is affiliated with Unity Hospital. He received his medical degree from Yale University School of Medicine. Dr. Amatruda accepts several types of health insurance, listed below. He is one of 7 doctors at Unity Hospital who specialize in Hematology.

Are you Dr. Thomas Amatruda? Claim your profile to make edits or add details. Edit Profile

Office Location

See Contact Information

Specialty & Clinical Interests

Hematologist: General Hematology

Hospital Affiliation

Unity Hospital

Education & Medical Training

UCLA Medical Center
Fellowship, Hematology/Oncology, 1982 - 1985

University of California at San Francisco
Fellowship, Internal Medicine, 1978 - 1981

Yale University School of Medicine
Class of 1978

California Institute of Technology
Post Doctoral Fellowship, Biology, Signal Transduction, 1985 - 1992

Certifications & Licensure

American Board of Internal Medicine
Certified in Hematology

American Board of Internal Medicine
Certified in Internal Medicine

American Board of Internal Medicine
Certified in Medical Oncology

MN State Medical License
Active through 2013

Awards, Honors & Recognition

Meaningful Use Stage 1 Certification, Centers for Medicare & Medicaid Services

Publications & Presentations

The Society for Immunotherapy of Cancer consensus statement on tumour immunotherapy for the treatment of cutaneous melanoma.
Kaufman, H. L.,Kirkwood, J. M.,Hodi, F. S.,Agarwala, S.,Amatruda, T.,Bines, S. D.,Clark, J. I.,Curti, B.,Ernstoff, M. S.,Gajewski, T.,Gonzalez, R.,Hyde, L. J.,Lawson, D.,Lotze, M.,Lutzky, J.,Margolin, K.,McDermott, D. F.,Morton, D.,Pavlick, A.,Richards, J. M.,Sharfman, W.,Sondak, V. K.,Sosman, J.,Steel, S.,Tarhini, A.,Thompson, J. A.,Titze, J.,Urba, W.,White, R.,Atkins, M. B.

A randomized phase 2 study of temozolomide and bevacizumab or nab-paclitaxel, carboplatin, and bevacizumab in patients with unresectable stage IV melanoma : A North Central Cancer Treatment Group study, N0775.
Kottschade, L. A.,Suman, V. J.,Perez, D. G.,McWilliams, R. R.,Kaur, J. S.,Amatruda, T. T.,Geoffroy, F. J.,Gross, H. M.,Cohen, P. A.,Jaslowski, A. J.,Kosel, M. L.,Markovic, S. N.

Is Age ≥ 70 Years an Important Predictor of Adverse Events Among Patients Enrolled in Metastatic Melanoma Trials? Findings from Pooled Analyses of Therapeutic Trials.
Jatoi, A., Allred, J. B., Suman, V. J., Creagan, E. T., Croghan, G. A., Amatruda, T., Markovic, S. N.

See all 8 publications

Insurances Accepted

  • Aetna Choice POS II
  • BCBS Blue Card PPO
  • BCBS Illinois PPO
  • BCBS Minnesota Blue Cross Accord
  • CIGNA Open Access
  • First Health PPO
  • Great West PPO
  • Humana ChoiceCare Network PPO
  • Multiplan PHCS PPO
  • Multiplan PPO
  • United Healthcare - Direct Choice Plus POS
  • United Healthcare - Direct Options PPO
  • WEA Trust Preferred Provider Plan - Trust Pref
Find More Doctors
Doctor Finder

Our Doctor Finder includes most U.S. physicians. Doctors are not ranked, learn more.

Browse Doctors by



Search all Doctors

Profiles by Doximity

Your Message Has Been Submitted

As part of our research on the correction you submitted, you may be contacted at the email address provided.

Sorry, Your Message Could Not Be Submitted

Please try again later, or E-mail your message to doctors@usnews.com and include the Web address (URL) of the page that contains incorrect information.